Ethylmalonic encephalopathy

Application of improved biochemical and molecular diagnostic approaches

A. Drousiotou, I. Dimeo, R. Mineri, Th Georgiou, G. Stylianidou, V. Tiranti

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Ethylmalonic encephalopathy (EE, OMIM # 602473) is an autosomal recessive metabolic disorder of infancy affecting the brain, the gastrointestinal tract and peripheral vessels. It is caused by a defect in the ETHE1 gene product, which was recently shown to be part of a metabolic pathway devoted to sulphide detoxification. We report the application of improved biochemical and molecular approaches to the diagnosis of three cases of EE from two unrelated Cypriot families. The children presented all the typical biochemical hallmarks of the disease including elevated lactate and butyrylcarnitine in blood and elevated urinary excretion of ethylmalonic acid, 2-methylsuccinate, isobutyrylglycine and isovalerylglycine. We also detected an elevated level of thiosulphate in urine, which we propose as an additional biochemical marker of the disease. The proband of the first family was shown to be a compound heterozygote for a missense mutation in exon 5, L185R, and a deletion of exon 4. The deletion was identified using quantitative real-time polymerase chain reaction (qRT-PCR). Using the same technique, the proband of the second family was found to be homozygous for the exon 4 deletion. A prenatal diagnosis was performed for the second family using qRT-PCR, thus establishing the usefulness of RT-PCR in prenatal diagnosis.

Original languageEnglish
Pages (from-to)385-390
Number of pages6
JournalClinical Genetics
Volume79
Issue number4
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Molecular Pathology
Exons
Prenatal Diagnosis
Real-Time Polymerase Chain Reaction
Genetic Databases
Thiosulfates
Sulfides
Missense Mutation
Heterozygote
Metabolic Networks and Pathways
Gastrointestinal Tract
Lactic Acid
Biomarkers
Urine
Polymerase Chain Reaction
Ethylmalonic encephalopathy
Brain
Genes

Keywords

  • Cypriot
  • Ethylmalonic encephalopathy
  • Mutation analysis
  • Real-time PCR
  • Thiosulphate

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Ethylmalonic encephalopathy : Application of improved biochemical and molecular diagnostic approaches. / Drousiotou, A.; Dimeo, I.; Mineri, R.; Georgiou, Th; Stylianidou, G.; Tiranti, V.

In: Clinical Genetics, Vol. 79, No. 4, 04.2011, p. 385-390.

Research output: Contribution to journalArticle

Drousiotou, A. ; Dimeo, I. ; Mineri, R. ; Georgiou, Th ; Stylianidou, G. ; Tiranti, V. / Ethylmalonic encephalopathy : Application of improved biochemical and molecular diagnostic approaches. In: Clinical Genetics. 2011 ; Vol. 79, No. 4. pp. 385-390.
@article{69030e35978f4da0b97ea973416466f4,
title = "Ethylmalonic encephalopathy: Application of improved biochemical and molecular diagnostic approaches",
abstract = "Ethylmalonic encephalopathy (EE, OMIM # 602473) is an autosomal recessive metabolic disorder of infancy affecting the brain, the gastrointestinal tract and peripheral vessels. It is caused by a defect in the ETHE1 gene product, which was recently shown to be part of a metabolic pathway devoted to sulphide detoxification. We report the application of improved biochemical and molecular approaches to the diagnosis of three cases of EE from two unrelated Cypriot families. The children presented all the typical biochemical hallmarks of the disease including elevated lactate and butyrylcarnitine in blood and elevated urinary excretion of ethylmalonic acid, 2-methylsuccinate, isobutyrylglycine and isovalerylglycine. We also detected an elevated level of thiosulphate in urine, which we propose as an additional biochemical marker of the disease. The proband of the first family was shown to be a compound heterozygote for a missense mutation in exon 5, L185R, and a deletion of exon 4. The deletion was identified using quantitative real-time polymerase chain reaction (qRT-PCR). Using the same technique, the proband of the second family was found to be homozygous for the exon 4 deletion. A prenatal diagnosis was performed for the second family using qRT-PCR, thus establishing the usefulness of RT-PCR in prenatal diagnosis.",
keywords = "Cypriot, Ethylmalonic encephalopathy, Mutation analysis, Real-time PCR, Thiosulphate",
author = "A. Drousiotou and I. Dimeo and R. Mineri and Th Georgiou and G. Stylianidou and V. Tiranti",
year = "2011",
month = "4",
doi = "10.1111/j.1399-0004.2010.01457.x",
language = "English",
volume = "79",
pages = "385--390",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Ethylmalonic encephalopathy

T2 - Application of improved biochemical and molecular diagnostic approaches

AU - Drousiotou, A.

AU - Dimeo, I.

AU - Mineri, R.

AU - Georgiou, Th

AU - Stylianidou, G.

AU - Tiranti, V.

PY - 2011/4

Y1 - 2011/4

N2 - Ethylmalonic encephalopathy (EE, OMIM # 602473) is an autosomal recessive metabolic disorder of infancy affecting the brain, the gastrointestinal tract and peripheral vessels. It is caused by a defect in the ETHE1 gene product, which was recently shown to be part of a metabolic pathway devoted to sulphide detoxification. We report the application of improved biochemical and molecular approaches to the diagnosis of three cases of EE from two unrelated Cypriot families. The children presented all the typical biochemical hallmarks of the disease including elevated lactate and butyrylcarnitine in blood and elevated urinary excretion of ethylmalonic acid, 2-methylsuccinate, isobutyrylglycine and isovalerylglycine. We also detected an elevated level of thiosulphate in urine, which we propose as an additional biochemical marker of the disease. The proband of the first family was shown to be a compound heterozygote for a missense mutation in exon 5, L185R, and a deletion of exon 4. The deletion was identified using quantitative real-time polymerase chain reaction (qRT-PCR). Using the same technique, the proband of the second family was found to be homozygous for the exon 4 deletion. A prenatal diagnosis was performed for the second family using qRT-PCR, thus establishing the usefulness of RT-PCR in prenatal diagnosis.

AB - Ethylmalonic encephalopathy (EE, OMIM # 602473) is an autosomal recessive metabolic disorder of infancy affecting the brain, the gastrointestinal tract and peripheral vessels. It is caused by a defect in the ETHE1 gene product, which was recently shown to be part of a metabolic pathway devoted to sulphide detoxification. We report the application of improved biochemical and molecular approaches to the diagnosis of three cases of EE from two unrelated Cypriot families. The children presented all the typical biochemical hallmarks of the disease including elevated lactate and butyrylcarnitine in blood and elevated urinary excretion of ethylmalonic acid, 2-methylsuccinate, isobutyrylglycine and isovalerylglycine. We also detected an elevated level of thiosulphate in urine, which we propose as an additional biochemical marker of the disease. The proband of the first family was shown to be a compound heterozygote for a missense mutation in exon 5, L185R, and a deletion of exon 4. The deletion was identified using quantitative real-time polymerase chain reaction (qRT-PCR). Using the same technique, the proband of the second family was found to be homozygous for the exon 4 deletion. A prenatal diagnosis was performed for the second family using qRT-PCR, thus establishing the usefulness of RT-PCR in prenatal diagnosis.

KW - Cypriot

KW - Ethylmalonic encephalopathy

KW - Mutation analysis

KW - Real-time PCR

KW - Thiosulphate

UR - http://www.scopus.com/inward/record.url?scp=79952207040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952207040&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2010.01457.x

DO - 10.1111/j.1399-0004.2010.01457.x

M3 - Article

VL - 79

SP - 385

EP - 390

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 4

ER -